Pharma-Bio Serv Engages CorProminence LLC, to Provide Investor Relations Services
25 Fevereiro 2013 - 11:00AM
Marketwired
Pharma-Bio Serv Inc., ("Pharma-Bio Serv" or the "Company"), (OTCQB:
PBSV), a global compliance and validation services consulting
solutions provider, today announced it has engaged CorProminence
LLC, a leading investor relations and strategic advisory firm, to
assist in the Company's shareholder communication efforts.
CorProminence will assist the Company in expanding market awareness
and conveying the Company's key messages to the investment
community. CorProminence LLC, a boutique investor relations firm,
specializes in integrated corporate communications strategies for
small-cap companies.
"We are pleased to announce the engagement of CorProminence and
look forward to working with them," said Nélida Plaza, Acting
President and CEO of Pharma-Bio Serv and President of Puerto Rico
Operations.
Scott Gordon, President of CorProminence commented,
"CorProminence is well suited to assist Pharma-Bio Serv, and
effectively communicate their business and growth strategy to raise
awareness of the Company within the investment community. We look
forward to working with the team at Pharma-Bio Serv to help achieve
their goals."
About Pharma-Bio Serv
Inc.
Pharma-Bio Serv is a global compliance and validation services
consulting solutions provider, headquartered in Puerto Rico, with
operations in the U.S., Ireland and Spain. Pharma-Bio Serv's core
business is FDA and international agencies regulatory compliance
related services with integrated portfolio services including
microbiological and chemical testing services for clients in the
Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic,
Food and Allied Products industries, at our laboratory testing
facility in Puerto Rico. Our services also include "Integratek,"
our Microsoft Certified Partner information technology consulting
practice and the "Pharma Serv Academy" of training centers that
provide state-of-the-art technical and regulatory standards
seminars/training through conducted by our network of leading
industry experts in their fields, which include both in-house and
sourced resources. Our global team includes more than 275 leading
engineering and life science professionals, quality assurance
managers and directors.
Forward-Looking Statements
This news release contains "forward-looking statements" within
the meaning of the U.S. federal securities laws, which statements
may include information regarding the plans, intentions,
expectations, future financial performance, or future operating
performance of Pharma-Bio Serv. Forward-looking statements are
based on the expectations, estimates, or projections of management
as of the date of this news release. Although Pharma-Bio Serv's
management believes these expectations, estimates, or projections
to be reasonable as of the date of this news release,
forward-looking statements are inherently subject to significant
business risks, economic and competitive uncertainties, or other
contingencies, which could cause its actual results or performance
to differ materially from what may be expressed or implied in the
forward-looking statements. Important factors that could cause
Pharma-Bio Serv's actual results or performance to differ
materially from the forward-looking statements include those set
forth in the "Risk Factors" section of Pharma-Bio Serv's Annual
Report on Form 10-K for the year ended October 31, 2012 and in its
other filings with the Securities and Exchange Commission, which
filings are available on www.sec.gov. Pharma-Bio Serv disclaims any
intention or obligation to update or revise any forward-looking
statements to reflect subsequent events and circumstances, except
to the extent required by applicable law.
Investor Relations Contact: Scott Gordon CorProminence LLC
scottg@corprominence.com
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024